Cns Pharmaceuticals (CNSP) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-12.5
-8.69
-4.89
-1.08

Details

Expected EPS
-5
Actual EPS
-12.5
Surprise EPS
-7.5
Surprise Percent
+150%

Description

Cns Pharmaceuticals (CNSP) has reported earnings of -12.5 per share for Q4 2024.

0 Comments

Share your thoughts